Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

129.85 +4.52 (+3.61%)
Streaming Delayed Price Updated: 3:43 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,076,600
Open 127.49
Bid (Size) 129.72 (100)
Ask (Size) 129.99 (100)
Prev. Close 125.33
Today's Range 127.42 - 132.25
52wk Range 100.99 - 175.77
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Out-of-Favor Stocks We Keep Off Our Radar
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co... 
Via StockStory
News headline image
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind... 
Via StockStory

Performance

YTD
-21.0%
-21.0%
1 Month
+12.0%
+12.0%
3 Month
+1.5%
+1.5%
6 Month
-19.3%
-19.3%
1 Year
-1.4%
-1.4%

More News

Read More
News headline image
Why Repligen (RGEN) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence Economy
News headline image
1 Growth Stock with Explosive Upside and 2 Facing Headwinds
Via StockStory
Repligen Corp (NASDAQ:RGEN) Sees Pre-Market Gain After Q1 Earnings Beat Offsets Slight Revenue Miss ↗
Via Chartmill
Topics Earnings
News headline image
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy
News headline image
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
3 Small-Cap Stocks We Steer Clear Of
Via StockStory
News headline image
Repligen (RGEN) Shares Skyrocket, What You Need To Know
Via StockStory
Topics Artificial Intelligence Earnings Regulatory Compliance
News headline image
Repligen (RGEN) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates
Via StockStory
Topics Earnings
News headline image
Repligen (RGEN) Q1 Earnings Report Preview: What To Look For
Via StockStory
Topics Artificial Intelligence
News headline image
Why Repligen (RGEN) Shares Are Plunging Today
Via StockStory
Topics Economy Regulatory Compliance
News headline image
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know
Via StockStory
Topics Economy
News headline image
1 of Wall Street’s Favorite Stock to Own for Decades and 2 We Avoid
Via StockStory
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Avoid
Via StockStory
News headline image
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Government Stocks
News headline image
1 High-Flying Stock with Solid Fundamentals and 2 We Avoid
Via StockStory
News headline image
1 Cash-Heavy Stock to Target This Week and 2 We Question
Via StockStory
News headline image
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
News headline image
2 Growth Stocks Set to Flourishand 1 We Turn Down
Via StockStory
News headline image
3 Profitable Stocks We Keep Off Our Radar
Via StockStory
Brown Capital Dumps 190,000 AppFolio Shares Worth $45.1 Million ↗
Via The Motley Fool
News headline image
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy
News headline image
3 Healthcare Stocks We’re Skeptical Of
Via StockStory

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 129.85
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 06/09/26 03:43 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 7.23B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.